← Leaderboards
Jose M Galarza
Technovax, Inc.
$5,374,565
Attributed
$6,848,322
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,848,322 · 6
By mechanism
R44$4,428,657 · 2
R43$2,419,665 · 4
Top collaborators
- Innocent N Mbawuike3 shared
Others in their field
Top investigators on “Immunogenicity”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,963,650
- Lawrence Corey · Fred Hutchinson Cancer Center$378,262,806
- Barton F Haynes · Duke University$364,422,244
- Dennis R. Burton · Scripps Research Institute$311,593,259
- Peter B. Gilbert · Fred Hutchinson Cancer Center$200,471,907
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$172,054,560
Research focus
ImmunogenicityVirusVirus GeneticsBaseVaccinesSmall Business Innovation Research GrantVirus-Like ParticleGenetic MaterialsInfectionImmunizationStructureVaccine DevelopmentMammalian CellAntigensInfluenza Virus StrainInfluenza Virus VaccineVariantFerretsInfluenzaProductionEpitopesProtective EfficacyInfluenzavirusVaccine Efficacy
Grant awards (11)
Production and Testing of VLP-based RSV Vaccine$300,000
R43 · FY2020 · AI · contact PI
Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.$734,219
R44 · FY2019 · AI · contact PI
Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.$746,924
R44 · FY2018 · AI · contact PI
Development, Production and Testing of VLP based Respiratory Syncytial Virus (RSV$509,623
R43 · FY2014 · AI · contact PI
Broadly protective (universal) virus-like particle (VLP) based influenza vaccine$300,000
R43 · FY2014 · AI · contact PI
Broadly protective (universal) virus-like particle (VLP) based influenza vaccine$300,000
R43 · FY2013 · AI · contact PI
Development of Influenza Virus-Like Particle (VLP) Vaccines$1,153,679
R44 · FY2011 · AI · contact PI
Development of Influenza Virus-Like Particle (VLP) Vaccines$971,080
R44 · FY2010 · AI · contact PI
Development of Influenza Virus-Like Particle (VLP) Vaccines$822,755
R44 · FY2009 · AI · contact PI
Influenza Virus-like Particles As Vaccines$499,800
R43 · FY2006 · AI · contact PI
Influenza Virus-like Particles As Vaccines$510,242
R43 · FY2005 · AI